Summary

147.59 -2.51(-1.67%)07/07/2025
ICON Public Limited Company (ICLR)

Key Facts


Historical Returns
1 Day1 Week1 Month3 Months6 Months1 Year5 Years
-1.671.470.00-2.15-33.69-54.01-13.89


Price Chart Compare
Last 730 data points are shown. To view all data, Upgrade to PRO plan!


Fundamental Ratings
CategoryRating
Main RatingA-
Recommended RatingBuy
DCFStrong Buy
ROENeutral
ROABuy
Debt/EquitySell
P/ESell
P/BBuy


Earnings
  • ICLR reported last earnings on 2025-04-30 after the market.
  • An EPS of $3.19 was observed compared to an estimated EPS of $3.11, resulting in a surprise value of $0.08.
  • A revenue of $2,001 million was observed compared to an estimated revenue of $2,008 million, resulting in a surprise value of $-6 Million.


    • Key Statistics
    Trading Data
    Close147.59
    Open150.24
    High150.24
    Low146.56
    Volume1,120,559
    Change-2.51
    Change %-1.67
    Avg Volume (20 Days)1,155,679
    Volume/Avg Volume (20 Days) Ratio0.97
    52 Week Range125.10 - 347.72
    Price vs 52 Week High-57.55%
    Price vs 52 Week Low17.98%
    Range0.00
    Gap Up/Down-3.81
    Profitibility
    Market Capitalization (Mln)11,252
    Revenue per share100.1719
    Net Income per share9.2704
    Dividend Yield0.0000
    Dividend Share0.00%
    Valuations
    Enterprise Value0.00%
    PE Ratio15.9205
    PB Ratio0.0000
    PTB Ratio0.0000
    Liquidity
    Debt/Equity Ratio0.0000
    Net Debt/EBIDTA Ratio0.0000
    Current Ratio0.0000
    Enterprise Value and Cash Flow
    EV/Sales Ratio0.0000
    EV/EBIDTA Ratio0.0000
    EV/Free Cash Flow Ratio0.0000


    News
    07/07 07:15 EST - businesswire.com
    ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
    DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company's leadership position in the clinical research industry, cutting-edge...
    06/25 06:36 EST - seekingalpha.com
    ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?
    The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to repurchase $750 million of its outstanding common shares.
    06/23 06:30 EST - businesswire.com
    ICON plc Schedules Second Quarter 2025 Earnings Conference Call
    DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2025 Earnings Conference Call.
    06/02 12:49 EST - businesswire.com
    ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
    LOS ANGELES--(BUSINESS WIRE)--ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm.
    06/02 11:26 EST - zacks.com
    Here's Why You Should Retain ICLR Stock in Your Portfolio Now
    Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.
    06/02 04:12 EST - prnewswire.com
    ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR
    LOS ANGELES , June 2, 2025 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of the federal securities laws. Shareholders who purchased the Company's securities between July...
    05/27 10:01 EST - https://www.prnewswire.com
    Real World Evidence (RWE) Oncology Market to Reach $3.51 Billion by 2035, Growing at a CAGR of 14.7% from 2025--Exclusive Report by Meticulous Research®
    Market Growth Driven by Increasing Demand for Real-World Evidence in Drug Development, Rising Focus on Value-Based Healthcare, Growing Cancer Incidence Globally, and Advancements in Data Analytics and AI Technologies REDDING, Calif., May 27, 2025 /PRNewswire/ -- According to a new market research...
    05/27 08:30 EST - businesswire.com
    ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
    DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the William Blair 45th Annual Growth Stock Conference.
    05/19 16:15 EST - businesswire.com
    ICON releases its ICON Cares 2024 Report
    DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2024 Report.
    05/07 07:27 EST - businesswire.com
    Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
    DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for...
    05/05 08:01 EST - prnewswire.com
    ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall LAW FIRM
    LOS ANGELES , May 5, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR)  for violations of §§10(b) and 20(a) of the Securities...
    05/02 02:42 EST - seekingalpha.com
    ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript
    ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive Officer Nigel Clerkin - Chief Financial Officer Barry Balfe - Chief Operating Officer Conference...
    05/01 10:20 EST - zacks.com
    ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down
    ICLR posts mixed results in the first quarter of 2025 due to ongoing clinical development and market volatility.
    04/30 19:20 EST - zacks.com
    Icon PLC (ICLR) Beats Q1 Earnings Estimates
    Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago.
    04/30 16:15 EST - businesswire.com
    ICON Reports First Quarter 2025 Results
    DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2025 Results.
    04/29 10:15 EST - zacks.com
    What to Expect From These 3 MedTech Stocks This Earnings Season?
    Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.